cancer of the uterus carcinosarcoma of the uterus
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Female patients older than 18 year who are diagnosed with a histologically confirmed CSU. Patients will be asked to sign informed consent. Patients are also able to choose if they want to participate in a part of the study (molecular analysis, registration of clinical outcomes and/or participation in quality of life questionnaires). Patients who are already included for the CUS-study can for additionally join the CUS II study for the molecular analysis.
Exclusion criteria
Exclusion criteria: Patients who are not able to fill in the questionnaires due to language (Dutch) or who are not mentally competent are excluded for the part of quality of life.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| molecular characterization of the obtained tumor tissue, liquid biopsies and papsmear. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life-questionnaires and registration of clinical outcomes of included subjects. | — |
Countries
Netherlands
Outcome results
None listed